Compassionate use of remdesivir in children with severe COVID-19

DL Goldman, ML Aldrich, SHF Hagmann… - …, 2021 - publications.aap.org
OBJECTIVES: Remdesivir shortens time to recovery in adults with severe coronavirus
disease 2019 (COVID-19), but its efficacy and safety in children are unknown. We describe …
被引用次数：100 相关文章

Compassionate use of remdesivir in children with severe COVID-19.

DL Goldman, ML Aldrich, SHF Hagmann, A Bamford… - 2021 - cabidigitallibrary.org
OBJECTIVES: Remdesivir shortens time to recovery in adults with severe coronavirus
disease 2019 (COVID-19), but its efficacy and safety in children are unknown. We describe …

Compassionate use of remdesivir in children with severe covid-19

DL Goldman, ML Aldrich, SHF Hagmann… - …, 2021 - einstein.elsevierpure.com
OBJECTIVES: Remdesivir shortens time to recovery in adults with severe coronavirus
disease 2019 (COVID-19), but its efficacy and safety in children are unknown. We describe …

Compassionate Use of Remdesivir in Children With Severe COVID-19

DL Goldman, ML Aldrich, SHF Hagmann, A Bamford… - Pediatrics, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVES:</jats: title>< jats: p> Remdesivir shortens time to
recovery in adults with severe coronavirus disease 2019 (COVID-19), but its efficacy and …

Compassionate Use of Remdesivir in Children With Severe COVID-19

D Goldman, M Aldrich, S Hagmann, A Bamford… - PEDIATRICS, 2021 - boa.unimib.it
OBJECTIVES: Remdesivir shortens time to recovery in adults with severe coronavirus
disease 2019 (COVID-19), but its efficacy and safety in children are unknown. We describe …

Compassionate Use of Remdesivir in Children With Severe COVID-19.

DL Goldman, ML Aldrich, SHF Hagmann, A Bamford… - Pediatrics, 2021 - europepmc.org
Remdesivir shortens time to recovery in adults with severe coronavirus disease 2019
(COVID-19), but its efficacy and safety in children are unknown. We describe outcomes in …

Compassionate Use of Remdesivir in Children With Severe COVID-19

DL Goldman, ML Aldrich, SHF Hagmann… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives Remdesivir shortens time to recovery in adults with severe coronavirus disease
2019 (COVID-19), but its efficacy and safety in children are unknown. We describe outcomes …